Status:
RECRUITING
Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy
Lead Sponsor:
Sohag University
Conditions:
Diabetic Polyneuropathy
Eligibility:
All Genders
33-65 years
Brief Summary
The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilam...
Eligibility Criteria
Inclusion
- ü Age: 30-55 y
- ü Type of diabetes: Type 2
- ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria
Exclusion
- Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06514846
Start Date
June 1 2023
End Date
June 1 2025
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medecine Sohag university
Sohag, Egypt